NCT04698889

Brief Summary

Human milk, despite a much lower protein content, is as effective as cow milk on insulin stimulation under iso-lactose conditions. The causes for such a similar potency are unknown. This effect could be due to incretin and amino-acid responses, and/or to milk-protein interactions.In this study the investigators will address the above question(s) by testing, in young healthy volunteers, the effects of natural cow and human milk, as well as of the manipulation of the casein and whey protein content in cow milk, on insulin, C-peptide, GLP-1 and GIP secretion, as well as on circulating amino acids.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 7, 2015

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2019

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2020

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 7, 2021

Completed
Last Updated

January 7, 2021

Status Verified

January 1, 2021

Enrollment Period

3.8 years

First QC Date

December 14, 2020

Last Update Submit

January 6, 2021

Conditions

Keywords

cow milkhuman milkincretinscaseinwhey proteins

Outcome Measures

Primary Outcomes (2)

  • Plasma insulin and c-peptide

    microunits and nanomoles

    1 year

  • Plasma GIP: glucose-inhibitory polypeptide and GLP-1: glucagon-like-polypeptide-1

    picomol/L and picogram/mL

    1 year

Secondary Outcomes (1)

  • Plasma Amino acids

    2 years

Study Arms (4)

Cow milk

ACTIVE COMPARATOR

Administration of natural cow whole milk

Dietary Supplement: natural cow

Human milk

ACTIVE COMPARATOR

Administration of natural human milk

Dietary Supplement: natural human

Modified cow milk - low protein

ACTIVE COMPARATOR

Administration of modified cow milk at low protein content

Dietary Supplement: low protein cow milk

Modified cow milk - high protein

ACTIVE COMPARATOR

Administration of modified cow milk at high protein content

Dietary Supplement: high protein cow milk

Interventions

natural cowDIETARY_SUPPLEMENT
Cow milk
high protein cow milkDIETARY_SUPPLEMENT
Modified cow milk - high protein
natural humanDIETARY_SUPPLEMENT
Human milk
low protein cow milkDIETARY_SUPPLEMENT
Modified cow milk - low protein

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20-35 yrs
  • Both sexes
  • Healthy
  • In post-absorptive state
  • Hemoglobin Hb1c values within normal values.
  • Previous regular, moderate physical activity
  • Stable body weight and regular dietary habits.

You may not qualify if:

  • Familial or personal history of diabetes.
  • Altered fasting glucose and/ or impaired glucose tolerance.
  • Any metabolic, hormonal, hepatic, renal, and cardiovascular disease.
  • Current drug treatments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Subjects allocated to receive one or more milk types in random order on different occasions, spaced by at least two weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD

Study Record Dates

First Submitted

December 14, 2020

First Posted

January 7, 2021

Study Start

April 7, 2015

Primary Completion

February 5, 2019

Study Completion

October 1, 2020

Last Updated

January 7, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share